Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Sutherland, Colin J ^a,b   Laundy, Matt ^a   Price, Nicholas ^c   Burke, Martina ^b   Fivelman, Quinton L ^b   Pasvol, Geoffrey ^d   Klein, John L ^c   Chiodini, Peter L ^a,b  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CYTOCHROME B; ANTIMALARIAL AGENT; ATOVAQUONE; ATOVAQUONE PROGUANIL; ATOVAQUONE-PROGUANIL; PROGUANIL; PROTOZOAL DNA;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALARIA; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; ANIMAL; DRUG COMBINATION; DRUG EFFECT; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; MIDDLE AGED; MUTATION; PARASITOLOGY; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; TIME;

ADULT; ANIMALS; ANTIMALARIALS; ATOVAQUONE; CHILD, PRESCHOOL; CHLOROGUANIDE; CYTOCHROMES B; DNA, PROTOZOAN; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MUTATION; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RECURRENCE; TIME FACTORS; TREATMENT FAILURE;

EID: 60349110965     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-240     Document Type: Article

References (11)

1. Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. PL Chiodini CP Conlon DB Hutchinson JA Farquhar AP Hall TE Peto H Birley DA Warrell, J Antimicrob Chemother 1995 36 1073 1078 10.1093/jac/36.6.1073 8821609
2. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. IK Srivastava JM Morrisey E Darrouzet F Daldal AB Vaidya, Mol Microbiol 1999 33 704 711 10.1046/j.1365-2958.1999.01515.x 10447880
3. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. QL Fivelman GA Butcher IS Adagu DC Warhurst G Pasvol, Malar J 2002 1 1 12057021 10.1186/1475-2875-1-1
4. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. O Wichmann N Muehlberger T Jelinek M Alifrangis G Peyerl-Hoffmann M Muhlen MP Grobusch J Gascon A Matteelli H Laferl Z Bisoffi S Ehrhardt J Cuadros C Hatz I Gjorup P McWhinney J Beran S da Cunha M Schulze H Kollaritsch P Kern G Fry J Richter European Network on Surveillance of Imported Infectious Diseases, J Infect Dis 2004 190 1541 1546 10.1086/424469 15478057
5. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. L Musset O Bouchaud S Matheron L Massias J Le Bras, Microbes Infect 2006 8 2599 2604 10.1016/j.micinf.2006.07. 011 16962361
6. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa. CT Happi GO Gbotosho OA Folarin D Milner O Sarr A Sowunmi DE Kyle WK Milhous DF Wirth AM Oduola, Malar J 2006 5 82 17020611 10.1186/1475-2875-5-82
7. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. M Korsinczky N Chen B Kotecka A Saul K Rieckmann Q Cheng, Antimicrob Agents Chemother 2000 44 2100 2108 10898682 10.1128/AAC.44.8.2100-2108.2000
8. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene. O Wichmann M Muehlen H Gruss FP Mockenhaupt N Suttorp T Jelinek, Malar J 2004 3 14 15186499 10.1186/1475-2875-3-14
9. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa. S Kuhn MJ Gill KC Kain, Am J Trop Med Hyg 2005 72 407 9 15827276
10. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. C Roper R Pearce B Bredenkamp J Gumede C Drakeley F Mosha D Chandramohan B Sharp, Lancet 2003 361 1174 1181 10.1016/S0140-6736(03) 12951-0 12686039
11. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. B Schwöebel M Alifrangis A Salanti T Jelinek, Malar J 2003 2 5 12665429 10.1186/1475-2875-2-5